What is the address of SHB Medical?

The registered office of SHB Medical is located at Corsicalaan 5, 2950 Kapellen.

Is SHB Medical still active?

Yes. According to the CBE (29 October 2026) SHB Medical is active, legal situation “Normale toestand”, started on 1 December 2020.

Is SHB Medical registered on Peppol?

Yes, SHB Medical is registered on the Peppol network with ID 0208:0758933047.

What is the enterprise number of SHB Medical?

The enterprise number of SHB Medical is BE0758933047.

When was SHB Medical founded?

SHB Medical was founded on 1 December 2020.

Who are the directors of SHB Medical?

According to the 2025 annual accounts, the directors of SHB Medical are: Sarah Bots.

Is SHB Medical a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 December 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SHB Medical make in 2025?

SHB Medical posted a profit after taxes of € 92,730 in financial year 2025.

What is the revenue of SHB Medical?

As a small company, SHB Medical is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 125,507.

SHB Medical (Private Limited) - Kapellen - BE0758933047

Dossier SHB Medical, printed on 29 October 2026 from databakkes.be/en/0758933047/shb-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SHB Medical from Kapellen, company number BE0758933047, closed financial year 2025 with a result of € 92,730 after tax. For that financial year SHB Medical recorded a gross margin of € 125,507 and equity of € 23,338. Compared with financial year 2024, the result moved from € 84,774 to € 92,730. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 24, 2026.

What it is worth Growing

€ 23,338

▲ 120% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 92,730

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 170,227

▲ 49% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 80,000 paid out

86 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,372

▼ 85% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,177

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 596

▼ 47% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 74,761 Gross margin 2022: € 74,761 First fiscal year in the series	€ 105,854 Gross margin 2023: € 105,854 ▲ 42% vs 2022 (€ 74,761) Favourable step	€ 114,742 Gross margin 2024: € 114,742 ▲ 8% vs 2023 (€ 105,854) Favourable step	€ 125,507 Gross margin 2025: € 125,507 ▲ 9% vs 2024 (€ 114,742) Favourable step	▲ 9%
Profit after taxes	€ 52,045 Profit after taxes 2022: € 52,045 First fiscal year in the series	€ 77,666 Profit after taxes 2023: € 77,666 ▲ 49% vs 2022 (€ 52,045) Favourable step	€ 84,774 Profit after taxes 2024: € 84,774 ▲ 9% vs 2023 (€ 77,666) Favourable step	€ 92,730 Profit after taxes 2025: € 92,730 ▲ 9% vs 2024 (€ 84,774) Favourable step	▲ 9%
Equity	€ 63,167 Equity 2022: € 63,167 First fiscal year in the series	€ 140,834 Equity 2023: € 140,834 ▲ 123% vs 2022 (€ 63,167) Favourable step	€ 10,608 Equity 2024: € 10,608 ▼ 92% vs 2023 (€ 140,834) Unfavourable step	€ 23,338 Equity 2025: € 23,338 ▲ 120% vs 2024 (€ 10,608) Favourable step	▲ 120%
Total debts	€ 17,362 Total debts 2022: € 17,362 First fiscal year in the series	€ 10,127 Total debts 2023: € 10,127 ▼ 42% vs 2022 (€ 17,362) Favourable step	€ 190,319 Total debts 2024: € 190,319 ▲ € 180,192 vs 2023 (€ 10,127) Unfavourable step	€ 216,672 Total debts 2025: € 216,672 ▲ 14% vs 2024 (€ 190,319) Unfavourable step	▲ 14%
Cash	€ 34,310 Cash 2022: € 34,310 First fiscal year in the series	€ 39,507 Cash 2023: € 39,507 ▲ 15% vs 2022 (€ 34,310) Favourable step	€ 114,199 Cash 2024: € 114,199 ▲ 189% vs 2023 (€ 39,507) Favourable step	€ 170,227 Cash 2025: € 170,227 ▲ 49% vs 2024 (€ 114,199) Favourable step	▲ 49%
Retained profit	€ 58,167 Retained profit 2022: € 58,167 First fiscal year in the series	€ 135,834 Retained profit 2023: € 135,834 ▲ 134% vs 2022 (€ 58,167) Favourable step	€ 5,608 Retained profit 2024: € 5,608 ▼ 96% vs 2023 (€ 135,834) Unfavourable step	€ 18,338 Retained profit 2025: € 18,338 ▲ 227% vs 2024 (€ 5,608) Favourable step	▲ 227%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 215,000 Dividend 2024: € 215,000 Unchanged (€ 0) Unchanged	€ 80,000 Dividend 2025: € 80,000 ▼ 63% vs 2024 (€ 215,000) Unchanged	▼ 63%
Bank debt	€ 15,101 Bank debt 2022: € 15,101 First fiscal year in the series	€ 3,032 Bank debt 2023: € 3,032 ▼ 80% vs 2022 (€ 15,101) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 3,032) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 80,529 Balance sheet total 2022: € 80,529 First fiscal year in the series	€ 150,961 Balance sheet total 2023: € 150,961 ▲ 87% vs 2022 (€ 80,529) Unchanged	€ 200,927 Balance sheet total 2024: € 200,927 ▲ 33% vs 2023 (€ 150,961) Unchanged	€ 240,010 Balance sheet total 2025: € 240,010 ▲ 19% vs 2024 (€ 200,927) Unchanged	▲ 19%

Key figures of SHB Medical, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SHB Medical?

What happened at SHB Medical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 24, 2026 New annual accounts for financial year 2025: profit of € 92,730 (▲ 9% vs 2024). Source: NBB ↗
Dec 1, 2020 New establishment in Kapellen. KBO
Dec 1, 2020 Start of the company according to the CBE. KBO

In short

From € 52,045 profit in 2022 to € 92,730 profit in 2025.

Paid € 86,692 in corporate taxes since 2022.

Best year ever: 2025, with € 92,730 profit.

Paid out € 295,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Sarah Bots

SHB Medical

Zorggroep Noord

Behind SHB Medical is Sarah Bots. Sarah Bots is also behind Zorggroep Noord.

Directors

According to the 2025 annual accounts

Sarah Bots

Director

Also active at: Zorggroep Noord

Establishments

Establishment units

Physical locations of this company

Registered office

Corsicalaan 5

2950 Kapellen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

MOVEO SANO

€ 65,189 gross margin · 2025

Zorggroep Noord same network

€ 135,156 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0758.933.047
VAT number: BE 0758.933.047
Registered office: Corsicalaan 5, 2950 Kapellen
Names & denominations: SHB Medical
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 December 2020
Peppol: Active · Active since 24 Nov 2023

View on CBE Public ↗ Annual accounts (NBB) ↗